Alto Ingredients, Inc. (NASDAQ:ALTO ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations, Alliance Advisors IR Bryon McGregor - President
Alto Ingredients (ALTO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.17 per share a year ago.
- Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization  Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA -
PEKIN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it wi
PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announ
PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announ
Alto Ingredients, Inc. (NASDAQ:ALTO ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors IR Bryon McGregor - President and CEO Rob O
- Implemented Cost Savings Expected to Yield Approximately $8 Million Annually - - Integrated Accretive Acquisition of a Beverage-grade Liquid CO 2 Processor - - Considering Asset Sales, a Merger or O
PEKIN, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that
PEKIN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it w
Alto Ingredients Could Soon Have The Right Recipe For A Rebound
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel
- Secures improved, long-term CO2 sales contract,creating immediate bottom-line accretion and future financial upside -
- Plant to Operate as a Terminal - PEKIN, Ill., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and e
Three weeks ago, Alto Ingredients reported another set of disappointing quarterly results, which caused the stock price to crater by almost 40%. Despite favorable market conditions, the company misse
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE